paul whiting

Dr. paul whiting

orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1996 in Trends in Neurosciences
Verified
Journal Article
Closed access
RMRuth M. McKernan
Ruth M. McKernan
PWpaul whiting
paul whiting

1 June 2000 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RMR. M. McKernan
R. M. McKernan
TRT. W. Rosahl
T. W. Rosahl
DRD. S. Reynolds
D. S. Reynolds
CSC. Sur
C. Sur
KWK. A. Wafford
K. A. Wafford
PWpaul whiting
paul whiting

19 March 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LCLyndon da Cruz
Lyndon da Cruz
KFKate Fynes
Kate Fynes
OGOdysseas Georgiadis
Odysseas Georgiadis
JKJulie Kerby
Julie Kerby
YLYvonne H Luo
Yvonne H Luo
PCPeter J Coffey
Peter J Coffey

1 July 2012 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
SCStuart M Chambers
Stuart M Chambers
YQYuchen Qi
Yuchen Qi
YMYvonne Mica
Yvonne Mica
GLGabsang Lee
Gabsang Lee
XZXin-Jun Zhang
Xin-Jun Zhang
LSLorenz Studer
Lorenz Studer
Chambers et al. use a combination of small-molecule pathway inhibitors to rapidly differentiate human pluripotent stem cells into nociceptors, a type of sensory neuron. The conversion occurs about three-fold faster than during development, suggesting that pathway inhibition may offer a general approach for speeding up the generation of specific cell types in vitro. Considerable progress has been made in identifying signaling pathways that direct the differentiation of human pluripotent stem cells (hPSCs) into specialized cell types, including neurons. However, differentiation of hPSCs with extrinsic factors is a slow, step-wise process, mimicking the protracted timing of human development. Using a small-molecule screen, we identified a combination of five small-molecule pathway inhibitors that yield hPSC-derived neurons at >75% efficiency within 10 d of differentiation. The resulting neurons express canonical markers and functional properties of human nociceptors, including tetrodotoxin (TTX)-resistant, SCN10A-dependent sodium currents and response to nociceptive stimuli such as ATP and capsaicin. Neuronal fate acquisition occurs about threefold faster than during in vivo development1, suggesting that use of small-molecule pathway inhibitors could become a general strategy for accelerating developmental timing in vitro. The quick and high-efficiency derivation of nociceptors offers unprecedented access to this medically relevant cell type for studies of human pain.

18 November 2005 in Science
Verified
Journal Article
Closed access
PDF file
JMJ. Kirsty Millar
J. Kirsty Millar
BPBenjamin S. Pickard
Benjamin S. Pickard
SMShaun Mackie
Shaun Mackie
RJRachel James
Rachel James
SCSheila Christie
Sheila Christie
DPDavid J. Porteous
David J. Porteous
The disrupted in schizophrenia 1 ( DISC1 ) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B ( PDE4B ) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3′,5′-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.

1 July 2002 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
NCNeil Collinson
Neil Collinson
FKFrederick M. Kuenzi
Frederick M. Kuenzi
WJWolfgang Jarolimek
Wolfgang Jarolimek
KMKaren A. Maubach
Karen A. Maubach
RCRosa Cothliff
Rosa Cothliff
TRThomas W. Rosahl
Thomas W. Rosahl
The α5 subunit of the GABAA receptor is localized mainly to the hippocampus of the mammalian brain. The significance of this rather distinct localization and the function of α5-containing GABAA receptors has been explored by targeted disruption of the α5 gene in mice. The α5 −/− mice showed a significantly improved performance in a water maze model of spatial learning, whereas the performance in non-hippocampal-dependent learning and in anxiety tasks were unaltered in comparison with wild-type controls. In the CA1 region of hippocampal brain slices from α5 −/− mice, the amplitude of the IPSCs was decreased, and paired-pulse facilitation of field EPSP (fEPSP) amplitudes was enhanced. These data suggest that α5-containing GABAA receptors play a key role in cognitive processes by controlling a component of synaptic transmission in the CA1 region of the hippocampus.